Oramed Pharmaceuticals
ORMP
#8928
Rank
โ‚น8.16 B
Marketcap
โ‚น202.48
Share price
0.42%
Change (1 day)
12.70%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): โ‚น2.05 Billion

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of โ‚น0.60 Billion, an increase over its 2022 earnings that were of -โ‚น3.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚น2.05 B238.47%
2023 โ‚น0.60 B-119.45%
2022 -โ‚น3.12 Billion39.17%
2021 -โ‚น2.24 Billion73.93%
2020 -โ‚น1.29 Billion18.53%
2019 -โ‚น1.09 Billion-16.62%
2018 -โ‚น1.31 Billion38.32%
2017 -โ‚น0.95 Billion12.51%
2016 -โ‚น0.84 Billion25.01%
2015 -โ‚น0.67 Billion18.18%
2014 -โ‚น0.57 Billion39.72%
2013 -โ‚น0.41 Billion46.4%
2012 -โ‚น0.28 Billion128.32%
2011 -โ‚น0.13 Billion-51.47%
2010 -โ‚น0.25 Billion35.21%
2009 -โ‚น0.19 Billion
2007 -โ‚น0.3 Billion607.04%
2006 -โ‚น41.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น42.22 Billion-2,113.66%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.518 T 72,308.80%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
โ‚น630.21 B 29,960.63%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น1.28 B-38.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-โ‚น18.41 Billion-978.11%๐Ÿ‡บ๐Ÿ‡ธ USA